Immunophenotyping by flow cytometry plays an important role in evaluating the effects of new drug candidates on the immune system. As immunotherapies and cell and gene therapies become increasingly complex, immune assessments often require high-dimensional panels capable of characterizing multiple immune cell populations and markers simultaneously.
In this webinar, Michael Shea will discuss the development of a 30-plus-color spectral flow cytometry panel for characterizing a broad range of immune cell phenotypes in nonhuman primate peripheral blood. He will explore considerations for panel design and validation and how high-dimensional immunophenotyping can support immunotoxicology studies during drug development.
Topics to be covered:
- Designing flow cytometry assays for good laboratory practice studies in a contract research organization
- Selecting key markers for immunophenotyping nonhuman primate whole blood
- Developing and validating a 30-plus-color spectral flow cytometry panel for broad immune cell profiling
- Applying high-dimensional immunophenotyping to streamline immunotoxicology assessment during drug development
Wednesday, October 14th 2026 | 11:00 AM – 12:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speaker
Michael Shea, PhD
Science and Operations Manager, Immunotoxicology
Labcorp
